Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Allergen inhalation generates pro-inflammatory oxidised phosphatidylcholine associated with airway dysfunction

Christopher D. Pascoe, Aruni Jha, Min Hyung Ryu, Mirna Ragheb, Jignesh Vaghasiya, Sujata Basu, Gerald L. Stelmack, Sadeesh Srinathan, Biniam Kidane, Jason Kindrachuk, Paul M. O'Byrne, Gail M. Gauvreau, Amir Ravandi, Christopher Carlsten, Andrew J. Halayko on behalf of the Canadian Respiratory Research Network
European Respiratory Journal 2020; DOI: 10.1183/13993003.00839-2020
Christopher D. Pascoe
1Department of Physiology and Pathophysiology, University of Manitoba, Winnipeg, Canada
2Biology of Breathing Group, Children's Research Hospital of Manitoba, Winnipeg, Canada
9Co-first authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher D. Pascoe
Aruni Jha
1Department of Physiology and Pathophysiology, University of Manitoba, Winnipeg, Canada
2Biology of Breathing Group, Children's Research Hospital of Manitoba, Winnipeg, Canada
9Co-first authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min Hyung Ryu
3Department of Medicine, University of British Columbia, Vancouver, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mirna Ragheb
1Department of Physiology and Pathophysiology, University of Manitoba, Winnipeg, Canada
2Biology of Breathing Group, Children's Research Hospital of Manitoba, Winnipeg, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jignesh Vaghasiya
1Department of Physiology and Pathophysiology, University of Manitoba, Winnipeg, Canada
2Biology of Breathing Group, Children's Research Hospital of Manitoba, Winnipeg, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sujata Basu
2Biology of Breathing Group, Children's Research Hospital of Manitoba, Winnipeg, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerald L. Stelmack
2Biology of Breathing Group, Children's Research Hospital of Manitoba, Winnipeg, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sadeesh Srinathan
4Department of Surgery, University of Manitoba, Winnipeg, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Biniam Kidane
4Department of Surgery, University of Manitoba, Winnipeg, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason Kindrachuk
5Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul M. O'Byrne
6Firestone Institute of Respiratory Health, Department of Medicine, Hamilton, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul M. O'Byrne
Gail M. Gauvreau
6Firestone Institute of Respiratory Health, Department of Medicine, Hamilton, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amir Ravandi
7Department of Cardiology and Physiology, University of Manitoba, Winnipeg, Manitoba, Canada
8McMaster University, Hamilton, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Carlsten
3Department of Medicine, University of British Columbia, Vancouver, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew J. Halayko
1Department of Physiology and Pathophysiology, University of Manitoba, Winnipeg, Canada
2Biology of Breathing Group, Children's Research Hospital of Manitoba, Winnipeg, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew J. Halayko
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Rationale Oxidised phosphatidylcholines (OxPC) are produced under conditions of elevated oxidative stress and can contribute to human disease pathobiology. However, their role in allergic asthma is unexplored.

Objectives Characterise the OxPC profile in the airways after allergen challenge of people with airway hyperresponsiveness (AHR) or mild-asthma. Determine the capacity of OxPC to contribute to pathobiology associated with asthma.

Methods Using bronchoalveolar lavage (BAL) from two human cohorts, OxPC species were quantified using ultra high performance liquid chromatography tandem mass spectrometry. Murine thin cut lung slices (TCLS) were used to measure airway narrowing caused by OxPCs. Human airway smooth muscle (HASM) cells were exposed to OxPCs to assess concentration-associated changes in inflammatory phenotype and activation of signalling networks.

Measurements and Main Results OxPC profiles were different in the airways of people with or without AHR and correlated with methacholine responsiveness. Exposure of mild-asthmatics to allergens produced unique OxPC signatures that were associated with the late asthma response severity. OxPCs dose-dependently induced 15% airway narrowing in murine TCLS. In HASM, OxPCs dose-dependently increased the biosynthesis of cyclooxygenase-2, IL-6, IL-8, GM-CSF, and the production of oxylipins via protein kinase C-dependent pathways.

Conclusions Data from human cohorts and primary HASM culture we show that OxPCs are present in the airways, increase after allergen challenge, and correlate with metrics of a dysfunction. Furthermore, OxPCs may contribute to asthma pathobiology by promoting airway narrowing and inducing a pro-inflammatory phenotype and contraction of airway smooth muscle. OxPCs represent a potential novel target for treating oxidative stress-associated pathobiology in asthma.

Footnotes

This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.

Conflict of interest: Dr. Pascoe has nothing to disclose.

Conflict of interest: Dr. Jha has nothing to disclose.

Conflict of interest: Mr. Ryu has nothing to disclose.

Conflict of interest: Dr. Ragheb has nothing to disclose.

Conflict of interest: Dr. Vaghasiya has nothing to disclose.

Conflict of interest: Dr. Basu has nothing to disclose.

Conflict of interest: Dr. Stelmack has nothing to disclose.

Conflict of interest: Dr. Srinathan has nothing to disclose.

Conflict of interest: Dr. Kidane has nothing to disclose.

Conflict of interest: Dr. Kindrachuk has nothing to disclose.

Conflict of interest: POB HAS RECEIVED CONSULTING AND/OR SPEAKERS FEES FRO ASTRA ZENECA, GSK, CHIESI, MERANARI AND GRANTS IN AID FROM ASTRA ZENECA, MEDIMMUNE, GSK, NOVARTIS AND MERCK ALL OUTSIDE THE SUBMITTED WORK

Conflict of interest: Dr. Gauvreau has nothing to disclose.

Conflict of interest: Dr. Ravandi has nothing to disclose.

Conflict of interest: Dr. Carlsten has nothing to disclose.

Conflict of interest: Dr. Halayko has nothing to disclose.

  • Received March 24, 2020.
  • Accepted August 26, 2020.
  • Copyright ©ERS 2020
View Full Text

ERS Members

myERS - ERS members : log in with your myERS username and password.

INDIVIDUALS

Log in Login as an individual user.

Forgot your username or password?

LIBRARY USERS

Log in through your institution

If your library has a subscription, you may already be logged in via your IP address. Otherwise you may be able to log in via one of the following routes.
You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
If you think you should have access, please contact your librarian or email journals@ersnet.org

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top
View this article with LENS
Vol 57 Issue 4 Table of Contents
European Respiratory Journal: 57 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Allergen inhalation generates pro-inflammatory oxidised phosphatidylcholine associated with airway dysfunction
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Allergen inhalation generates pro-inflammatory oxidised phosphatidylcholine associated with airway dysfunction
Christopher D. Pascoe, Aruni Jha, Min Hyung Ryu, Mirna Ragheb, Jignesh Vaghasiya, Sujata Basu, Gerald L. Stelmack, Sadeesh Srinathan, Biniam Kidane, Jason Kindrachuk, Paul M. O'Byrne, Gail M. Gauvreau, Amir Ravandi, Christopher Carlsten, Andrew J. Halayko
European Respiratory Journal Jan 2020, 2000839; DOI: 10.1183/13993003.00839-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Allergen inhalation generates pro-inflammatory oxidised phosphatidylcholine associated with airway dysfunction
Christopher D. Pascoe, Aruni Jha, Min Hyung Ryu, Mirna Ragheb, Jignesh Vaghasiya, Sujata Basu, Gerald L. Stelmack, Sadeesh Srinathan, Biniam Kidane, Jason Kindrachuk, Paul M. O'Byrne, Gail M. Gauvreau, Amir Ravandi, Christopher Carlsten, Andrew J. Halayko
European Respiratory Journal Jan 2020, 2000839; DOI: 10.1183/13993003.00839-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
  • Info & Metrics
  • PDF

Subjects

  • Lung biology and experimental studies
  • Asthma and allergy
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Impact of obstructive sleep apnea and intermittent hypoxia on blood rheology – a translational study
  • Association between renin-angiotensin system and chronic lung allograft dysfunction
  • Identification of a novel subset of alveolar type 2 cells enriched in PD-L1 and expanded following pneumonectomy
Show more Original article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society